Article Information
History
- June 3, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Meriem Bekliz1,
- Kenneth Adea1,
- Manel Essaidi-Laziosi1,
- Jilian A Sacks2,
- Camille Escadafal2,
- Laurent Kaiser3,4,5 and
- Isabella Eckerle1,3,5,*
- 1Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland
- 2FIND, Geneva, Switzerland
- 3Division of Infectious Diseases, Geneva University Hospitals, 1205 Geneva, Switzerland
- 4Laboratory of Virology, Division of Infectious Diseases and Division of Laboratory Medicine, University Hospitals of Geneva & Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland
- 5Geneva Centre for Emerging Viral Diseases, University Hospitals Geneva, and University of Geneva, Switzerland
- ↵*Corresponding author: Isabella Eckerle, Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland.Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland., Tel: +41223729820;, Email: isabella.eckerle{at}hcuge.ch
Posted June 03, 2021.
Analytical comparison of nine SARS-CoV-2 antigen-detecting rapid diagnostic tests for emerging SARS-CoV-2 variants
